THE Therapeutic Goods
Administration has updated the
Prescribing Medicines in Pregnancy
Database, with the addition of a
number of new chemical entities.
These include cobimetinib
fumarate, ceritinib and
panobinostat (pregnancy category
D); lumacaftor/ivacaftor and
pirfenidone (category B3); selexipag
(category B1) and susoctocog alfa
(pregnancy category B2).
A number of medicine ingredient
names have also been updated in
the database to better align with
international naming conventions.The above article was sent to subscribers in Pharmacy Daily's issue from 23 May 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 May 16
MONTU Group, its subsidiary Alternaleaf Pty Ltd, and their common director Christopher Strauch are facing legal action by the Therapeutic Goods Administration (TGA) in the Federal Court of Australia for alleged unlawful advertising on the effectiveness of their medicinal cannabis products.
AUSTRALIA’S public hospitals are facing their lengthiest wait times on record for planned surgeries, with emergency departments struggling under access blockages, according to the latest annual Public Hospital Report Card by the Australian Medical Association (AMA).
THE University of South Australia has released a new study to help healthcare workers better support women with persistent pelvic pain, including symptoms that are suggestive of gynaecological, lower urinary tract, bowel, sexual, and pelvic floor dysfunction.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.